Boston Scientific (BSX) Grows IC Business With New FDA Nod
The AGENT DCB of Boston Scientific (BSX) is already available in Europe, parts of Asia Pacific and Latin America.
Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
US FDA approves Boston Scientific's heart device
Boston Scientific said on Friday the U.S. Food and Drug Administration has approved its device to treat a complication of heart disease.
Boston Scientific Corporation (BSX) Hits Fresh High: Is There Still Room to Run?
Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Should You Pick Boston Scientific Stock After A Solid Q4 And 13% Uptick This Year?
Boston Scientific BSX (NYSE: BSX) reported its Q4 results last month, with revenues and earnings comfortably beating the street estimates. The company reported revenue of $3.7 billion and adjusted ...
Boston Scientific (BSX) Surges 4.6%: Will the Rally Continue?
Boston Scientific (BSX) is benefitting from an impressive gain in MedSurg market share and the strong adoption of WATCHMAN FLX.
Boston Scientific (BSX) Completes First Case With Its PFA System
Boston Scientific (BSX) announces the completion of its first commercial cases with its FDA-cleared Farapulse PFA System in the United States.
Boston Scientific's (BSX) FARAPULSE PFA System Gets FDA Nod
Boston Scientific (BSX) secures FDA approval for the FARAPULSE PFA system.
Boston Scientific (BSX) Q4 Earnings Top, Operating Margin Falls
Boston Scientific (BSX) sees an increase in organic and operational revenues in its core business segments and geographies in the reported quarter.
Boston Scientific (BSX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall ...
Boston Scientific's stock jumps 5.8% after earnings beat and upbeat guidance
Boston Scientific Corp.'s stock BSX, +0.18% jumped 5.8% early Wednesday, after it beat estimates for the fourth quarter and offered upbeat guidance for 2024. The Marlborough, Mass.
Boston Scientific beats quarterly profit estimates on strong demand for heart devices
Medical device maker Boston Scientific beat Wall Street expectations for fourth-quarter profit on Wednesday, helped by strength in its heart devices unit.
FDA approves Boston Scientific's device for heart condition
Boston Scientific said on Wednesday the U.S. Food and Drug Administration has approved the company's device for a type of heart condition.
Boston Scientific (BSX) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Boston Scientific (BSX), delve into some of its key metrics to gain a deeper insight into the company's potential performanc...
What's in Store for Boston Scientific (BSX) in Q4 Earnings?
Boston Scientific (BSX) is expected to have witnessed strong growth of the WATCHMAN franchise in the fourth quarter, given the FDA approval of WATCHMAN FLX Pro in September.
Related Companies